Mammography Screening and Treatment of Breast Cancer in the Elderly.
Breast cancer patients of an advanced age will suffer from ailments related to both senescence and cancer. Some will have been denied access to screening programmes and will present with an advanced disease. Many will need the expertise of the geriatrician and the oncologist who will participate in specific case discussions to look at social and medical issues that will affect the treatment plan (with questions regarding surgery, radiation, drug therapy, rehabilitation, supportive care, and palliative care often intertwined). This paper reviews recommendations by the International Society of Geriatric Oncology (SIOG) task force which recently assessed the available evidence on breast cancer in elderly individuals, and provided evidence-based recommendations for the diagnosis and treatment of breast cancer in such individuals. Recommendations on the topics of screening, surgery, radiotherapy, (neo)adjuvant hormone treatment, and chemotherapy, and on metastatic disease have been given. Oncologists are now learning to take into account the physiological age of their patient, which is the reflection of a normal and sometimes abnormally accelerated loss of body reserves which is certainly related to chronological age but not precisely dictated by it. Understanding the biology of breast cancer will allow to optimally adapt the treatment of the elderly patient.
Aapro
Matti
M
IMO Clinique de Genolier, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
J Clin Oncol. 2004 Dec 1;22(23):4622-30
15505276
J Clin Oncol. 2006 Dec 1;24(34):5381-7
17135639
J Clin Oncol. 2005 Feb 1;23(4):783-91
15681522
J Clin Oncol. 2007 May 10;25(14):1824-31
17488980
Lancet. 2005 May 14-20;365(9472):1687-717
15894097
J Natl Cancer Inst. 2000 Apr 5;92(7):550-6
10749910
Lancet. 2005 Dec 17;366(9503):2087-106
16360786
J Clin Oncol. 2008 Apr 20;26(12):1956-64
18332474
J Clin Oncol. 1998 Jun;16(6):2018-24
9626198
J Clin Oncol. 2000 Apr;18(7):1412-22
10735888
J Natl Cancer Inst. 2008 Feb 20;100(4):252-60
18270335
Lancet Oncol. 2007 Dec;8(12):1101-1115
18054880
J Clin Oncol. 2007 Jul 20;25(21):3001-6
17548838
J Womens Health (Larchmt). 2003 Oct;12(8):799-808
14588130
Oncologist. 2004;9(5):497-506
15477634
J Clin Oncol. 2003 Oct 1;21(19):3580-7
12913099
J Clin Oncol. 2007 Aug 1;25(22):3259-65
17577015
Br J Surg. 1996 Jul;83(7):994-6
8813798
Cancer. 2004 Sep 15;101(6):1302-10
15316944
JAMA. 1992 Jul 1;268(1):57-62
1608114
Crit Rev Oncol Hematol. 2008 Feb;65(2):156-63
18082416
Eur J Cancer. 2007 Jan;43(1):14-34
17222747
Breast. 2007 Oct;16(5):462-8
17449249
J Clin Oncol. 2005 Oct 20;23(30):7703-20
16157938
J Clin Oncol. 2008 Apr 20;26(12):1972-9
18332471
Ann Oncol. 2008 Aug;19(8):1407-1416
18448451
J Am Coll Surg. 2008 Jan;206(1):66-75
18155570
J Natl Cancer Inst. 2003 Jun 4;95(11):779-90
12783932
Ann Oncol. 2008 Mar;19(3):420-32
17906299
Eur J Cancer. 2003 May;39(7):945-51
12706363
J Clin Oncol. 2007 May 10;25(14):1832-43
17488981